Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > JUST IN FROM KALYTERA GALACTIC HEADQUARTERS?????????????????

<< Previous

Bullboard Posts

Next >>

Post by losingmyshirton Oct 01, 2020 9:09am

179 Views

Post# 31647843

JUST IN FROM KALYTERA GALACTIC HEADQUARTERS?????????????????

GALACTIC HEADQUARTERS.

Just as I thought. They have moved their headquarters from planet earth and are now running the boileroom from another planet where there are no regulators. Damn these aliens and their pointy heads and green skin. Which planet are they on? Did they give you an adddress?
It could be Jupiter or more likely Uranus.

<< Previous

Bullboard Posts

Next >>

B2Gold stock buckles under news of labour strike in Mali